Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL239532 | 0.82 | — | — | |
| SCHEMBL4592491 | 0.70 | TSHR (0.41) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL4317430 | 0.70 | TSHR (0.41) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL24008838 | 0.68 | TDP1 (0.40) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL13639494 | 0.65 | — | — | |
| SCHEMBL27704000 | 0.60 | TSHR (0.38) | TSHRMAPK1HSD17B10TDP1THRB | |
| SCHEMBL12085045 | 0.59 | — | — | |
| SCHEMBL13758782 | 0.59 | — | — | |
| SCHEMBL9170906 | 0.59 | — | — | |
| SCHEMBL2619122 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 315 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4493066-B1 | PERSONAL UNIVERSAL DENDROGRAMIC HOLOGRAPHIC SIGNATURE FROM EEG DATA ANALYSIS FOR DIAGNOSIS OF NEURO-PSYCHIATRIC DISEASES | UNIV RAMOT (IL) | 2026-05-27 | — | — | EP | claimed |
| CN-116127534-B | Reduction and conversion of scalar to ceramic representation | 意法半导体(鲁塞)公司 | 2026-05-22 | — | — | CN | claimed |
| EP-4724891-A2 | METHODS AND SYSTEMS FOR ADDITION, MULTIPLICATION, SUBTRACTION, AND DIVISION OF RATIONAL NUMBERS ENCODED IN THE DOMAIN OF FAREY RATIONALS FOR MPC SYSTEMS | Algemetric, Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| US-12587357-B2 | Methods and systems for p-adic encoding and decoding of rational data for FHE systems | ALGEMETRIC, INC. (US) | 2026-03-24 | — | — | US | claimed |
| US-20260060970-A1 | Use of a Therapeutic Agent with Phosphodiesterase-7 Inhibitory Activity for the Treatment and Prevention of Diseases Associated with Chronic Fatigue, Exhaustion and/or Exertional Intolerance | MITODICURE GMBH (DE) | 2026-03-05 | — | — | US | claimed |
| US-12555683-B2 | EEG p-adic quantum potential in neuro-psychiatric diseases | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2026-02-17 | — | — | US | claimed |
| US-20250321716-A1 | COMPUTER LANGUAGE AND CODE FOR APPLICATION DEVELOPMENT AND ELECTRONIC AND OPTICAL COMMUNICATION | LYDEN ROBERT (US) | 2025-10-16 | — | — | US | claimed |
| EP-4572765-A1 | USE OF A THERAPEUTIC AGENT WITH PHOSPHODIESTERASE-7 INHIBITORY ACTIVITY FOR THE TREATMENT AND PREVENTION OF DISEASES ASSOCIATED WITH CHRONIC FATIGUE, EXHAUSTION AND/OR EXERTIONAL INTOLERANCE | Mitodicure GmbH (DE) | 2025-06-25 | — | — | EP | claimed |
| US-12284279-B2 | Reduction and conversion of a scalar to a τ-ADIC representation | STMICROELECTRONICS (ROUSSET) SAS (FR) | 2025-04-22 | — | — | US | claimed |
| US-12273453-B2 | Isogeny calculation device, isogeny calculation method, and computer program product | KABUSHIKI KAISHA TOSHIBA (JP) | 2025-04-08 | — | — | US | claimed |
| EP-4181459-A1 | REDUCTION AND CONVERSION OF A SCALAR TO A TAU-ADIC REPRESENTATION | STMicroelectronics (Rousset) SAS (FR) | 2023-05-17 | — | — | EP | claimed |
| CN-116127534-A | Reduction and conversion of scalar to ceramic representation | 意法半导体(鲁塞)公司 | 2023-05-16 | — | — | CN | claimed |
| CN-115826883-A | Automatic expansion method and system of bloom filter based on p-adic integer | 江西农业大学 | 2023-03-21 | — | — | CN | claimed |
| US-20220407719-A1 | METHODS AND SYSTEMS FOR ENCRYPTING RATIONAL NUMBERS AND ADDING RANDOMNESS TO RSA CRYPTOSYSTEMS USING P-ADIC NUMBERS | ALGEMETRIC, LLC (US) | 2022-12-22 | — | — | US | claimed |
| US-20220385448-A1 | METHODS AND SYSTEMS FOR PUBLIC AND PRIVATE-KEY LEVELED FULLY HOMOMORPHIC ENCRYPTION WITHOUT BOOTSTRAPPING WITH HENSEL CODES | ALGEMETRIC, LLC (US) | 2022-12-01 | — | — | US | claimed |
| WO-2022178331-A1 | METHODS AND SYSTEMS FOR PUBLIC AND PRIVATE-KEY LEVELED FULLY HOMOMORPHIC ENCRYPTION WITHOUT BOOTSTRAPPING WITH HENSEL CODES | X-Logos, LLC (US) | 2022-08-25 | — | — | WO | claimed |
| WO-2022064501-A1 | EEG P-ADIC QUANTUM POTENTIAL IN NEURO-PSYCHIATRIC DISEASES | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2022-03-31 | — | — | WO | claimed |
| WO-2022061184-A2 | METHODS AND SYSTEMS FOR ENCRYPTING RATIONAL NUMBERS AND ADDING RANDOMNESS TO RSA CRYPTOSYSTEMS USING P-ADIC NUMBERS | X-Logos, LLC (US) | 2022-03-24 | — | — | WO | claimed |
| WO-2022061188-A1 | METHODS AND SYSTEMS FOR DISTRIBUTED COMPUTATION WITHIN A FULLY HOMOMORPHIC ENCRYPTION SCHEME USING P-ADIC NUMBERS | X-Logos, LLC (US) | 2022-03-24 | — | — | WO | claimed |
| US-20220085973-A1 | METHODS AND SYSTEMS FOR DISTRIBUTED COMPUTATION WITHIN A FULLY HOMOMORPHIC ENCRYPTION SCHEME USING P-ADIC NUMBERS | X-Logos, LLC (US) | 2022-03-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260060970-A1 | Use of a Therapeutic Agent with Phosphodiesterase-7 Inhibitory Activity for the Treatment and Prevention of Diseases Associated with Chronic Fatigue, Exhaustion and/or Exertional Intolerance | PDE5A, PDE4C, PDE12 | TSHR 2373/4885MAPK1 1312/4885HSD17B10 2370/4885 |
| US-12555683-B2 | EEG p-adic quantum potential in neuro-psychiatric diseases | PNMT, PSEN2, PSEN1 | TSHR 3066/4885MAPK1 4040/4885HSD17B10 3825/4885 |
| US-12587357-B2 | Methods and systems for p-adic encoding and decoding of rational data for FHE systems | HPD, ASPH, APRT | TSHR 3940/4885MAPK1 4665/4885HSD17B10 464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.